Veru
(NASDAQ) VERU
Veru Financials at a Glance
Market Cap
$36.27M
Revenue (TTM)
$303.45K
Net Income (TTM)
$13.95M
EPS (TTM)
$-1.21
P/E Ratio
-1.86
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$2.08
Volume
192,818
Open
$2.25
Price
$2.08
Volume
192,818
Open
$2.25
Previous Close
$2.09
Daily Range
$2.05 - $2.28
52-Week Range
$2.05 - $7.40
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$2.08
Volume
192,818
Open
$2.25
Previous Close
$2.09
Daily Range
$2.05 - $2.28
52-Week Range
$2.05 - $7.40
VERU News
Is There any Hope for Veru Stock?
Is Veru a Buy?
Is It Too Late to Buy Veru Stock?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Veru
Industry
Pharmaceuticals
Sector
Health CareEmployees
20
CEO
Mitchell Shuster Steiner, MD
Website
www.verupharma.comHeadquarters
Miami, FL 33127, US
VERU Financials
Key Financial Metrics (TTM)
Gross Margin
-19%
Operating Margin
-63%
Net Income Margin
-46%
Return on Equity
-60%
Return on Capital
-50%
Return on Assets
-32%
Earnings Yield
-53.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$36.27M
Shares Outstanding
16.05M
Volume
192.82K
Avg. Volume
54.76K
Financials (TTM)
Gross Profit
$152.10K
Operating Income
$24.75M
EBITDA
$35.38M
Operating Cash Flow
$30.04M
Capital Expenditure
$1.08K
Free Cash Flow
$30.04M
Cash & ST Invst.
$18.32M
Total Debt
$3.12M
Veru Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$56.39K
N/A
Gross Profit
$28.19K
+196.1%
Gross Margin
50.00%
N/A
Market Cap
$36.27M
N/A
Market Cap/Employee
$172.73K
N/A
Employees
210
N/A
Net Income
$2.74M
+65.3%
EBITDA
$7.22M
+20.4%
Quarterly Fundamentals
Net Cash
$24.76M
+48.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.06M
-21.9%
Short Term Debt
$770.26K
+3.0%
Return on Assets
-32.39%
N/A
Return on Invested Capital
-50.47%
N/A
Free Cash Flow
$8.91M
-15.2%
Operating Cash Flow
$8.91M
-15.2%